Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52 | 100 | 72 | 29 | -23 |
| Depreciation Amortization | 6 | 28 | 21 | 13 | 7 |
| Accounts receivable | -159 | 2,150 | 1,953 | 1,832 | 2,186 |
| Accounts payable and accrued liabilities | -19 | -924 | -941 | -816 | -971 |
| Other Working Capital | -239 | 1,227 | 944 | 960 | 1,145 |
| Other Operating Activity | 182 | -1,218 | -1,006 | -1,011 | -1,212 |
| Operating Cash Flow | $-282 | $1,363 | $1,043 | $1,006 | $1,132 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -26 | -16 | -12 | N/A |
| Other Investing Activity | -9 | 5 | 4 | -7 | 2 |
| Investing Cash Flow | $-12 | $-22 | $-12 | $-18 | $2 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $0 | $0 | $0 | $N/A |
| Beginning Cash Position | 2,623 | 1,281 | 1,281 | 1,281 | 1,281 |
| End Cash Position | 2,329 | 2,623 | 2,312 | 2,269 | 2,414 |
| Net Cash Flow | $-294 | $1,342 | $1,031 | $988 | $1,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | -282 | 1,363 | 1,043 | 1,006 | 1,132 |
| Capital Expenditure | -3 | -26 | -16 | -12 | N/A |
| Free Cash Flow | -284 | 1,337 | 1,027 | 995 | 1,132 |